Squadron Capital Management LLC
Position in EPRX — Eupraxia Pharmaceuticals Inc.
CIK 2050709
WESTMONT, IL
Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,923,200
+$1,148,200 QoQ
Shares Held
680,000
+36.0% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squadron Capital Management LLC holds $280,459,987 across 30 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLMD |
Relmada Therapeutics, Inc.
|
7,350,000 | $50,862,000 | |
| 2 | CCCC |
C4 Therapeutics, Inc.
|
7,200,000 | $33,624,000 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
865,000 | $33,475,500 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
500,000 | $19,480,000 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
970,000 | $18,148,700 | |
| 6 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
3,700,000 | $17,945,000 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
290,000 | $11,782,700 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
335,000 | $9,996,400 |
All Filings in EPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,923,200 | 680,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,775,000 | 500,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||